KYLIE HAYS: Open Payments
NPI 1134741044 · STANLEY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,231 in 94 payments from 15 companies in 2025. Trend: 2023 $1,365 · 2024 $1,124 · 2025 $1,231
Food & beverage: $1,151Education: $80
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 46 | $387 |
| Novo Nordisk Inc | 14 | $255 |
| E.R. Squibb & Sons, L.L.C. | 11 | $156 |
| Lilly USA, LLC | 4 | $74 |
| UCB, Inc. | 3 | $70 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49 |
| Amgen Inc. | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| ABBVIE INC. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
Products named: Ozempic, Sotyktu, MOUNJARO, Bimzelx, XIFAXAN, AIRSUPRA, Wegovy, EVENITY.
Industry payments across KS — which companies pay providers there.
